NCT04450342终止不适用
A Prospective, Multi-center, Randomized Controlled Study to Evaluate the Safety and Efficacy of ARCR Augmented With REGENETEN™ Bioinductive Implant System in Full-thickness Tears (Large or Massive) Repair Versus ARCR Alone
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 119
- 试验地点
- 59
- 主要终点
- Retear Rate at 6 Months
研究概览
简要总结
The study is designed to assess the safety and efficacy of Arthroscopic rotator cuff repair (ARCR) augmented with REGENETEN in subjects requiring full-thickness rotator cuff tear repair or revision repair versus Arthroscopic rotator cuff repair alone.
详细描述
This study is a prospective, multi-center, randomized, controlled clinical study in the treatment of full thickness tears of the rotator cuff (large or massive ≥3 cm in AP or ML according to Cofield classification). The subjects meeting the inclusion/exclusion criteria specified in the protocol will receive either ARCR augmented with REGENETEN or ARCR alone. Subjects enrolled into the revision repair subject group will receive ARCR augmented with REGENETEN. The clinical follow-up evaluation will be performed preoperatively (Baseline), 2 weeks, 6 weeks, 3, 6, 12, and 24 months after surgery, respectively using subjective outcome measures, objective measures of movement and an MRI scan to assess the integrity of the repair and assess the re-tear rate. Health economic data will also be collected.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subject requires Arthroscopic rotator cuff repair (ARCR);
- •Subjects with a diagnosis of a symptomatic primary or recurrent (revision repair subject group), large or massive tear (≥ 3 cm AP/ML) of the supraspinatus and/or infraspinatus tendons amenable to repair. For screening purposes, a ≥ 2 cm AP/ML tear as measured on MRI will be eligible to proceed to the operative visit but will have to be confirmed as ≥ 3 cm on arthroscopy using a calibrated probe to proceed;
- •Subject is > 40 years of age (no upper limit);
- •Subject provides written informed consent for study participation using an Independent Ethical Committee (IEC) / Institutional Review Board (IRB) approved consent form;
- •Subject is willing and able to participate in required follow-up visits and is able to complete study activities.
排除标准
- •Subjects who are unable to tolerate magnetic resonance imaging (MRI), due to psychiatric or medical contraindications;
- •Subjects with Samilson-Prieto osteoarthritis > 2;
- •Subjects with current or prior infection of the ipsilateral shoulder;
- •Subjects with known hypersensitivity to bovine-derived materials;
- •Subjects with known inflammatory arthropathy, history of inflammatory arthropathy, or chronic joint disease;
- •Subjects with prior shoulder surgery (not including rotator cuff repair [revision repair subject group only], biceps tenodesis/tenotomy, distal clavicle excision [DCE], subacromial decompression);
- •Subjects with an irreparable or partially reparable rotator cuff tear;
- •Subjects with a subscapularis tear requiring repair;
- •Subjects requiring a concomitant labral fixation procedure;
- •Subjects requiring a concomitant os acromiale fixation procedure;
- •Subjects with glenohumeral joint instability (multiple dislocations/subluxations);
- •Subjects with a subacromial or intra-articular injection within 3 months prior to surgery;
- •Subjects with condition(s) that contraindicate or complicate outcomes of ARCR e.g., > Hamada 3 rotator cuff arthropathy on X-ray, Goutallier atrophy > Grade 3, proximal humeral fracture or scapular fracture, avascular necrosis of the humeral head or glenoid, history of immunodeficiency disorders, history of chronic inflammatory disorders, oral or injected steroid use in last 4 weeks;
- •Subjects who are pregnant or breast feeding;
- •Subjects who are currently involved in any injury litigation or workers compensation claims;
- •Subjects who are enrolled, or plan to enroll, in another clinical trial during this study that would affect the outcomes of this study;
- •Subjects with a history of noncompliance with medical treatment, physical therapy (PT)/rehabilitation, or clinical study participation
- •Subject who, in the opinion of the Investigator, has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, and drug or alcohol abuse;
- •Subjects who do not meet the indication or are contraindicated according to specific Smith+Nephew REGENETEN System's Instructions for Use (IFUs);
- •Subject that meets the definition of a Vulnerable Subject per ISO14155:2020 Section 3.44.
结局指标
主要结局
Retear Rate at 6 Months
时间窗: 6 months
Retear rate was measured by the percentage of retears 6 months after full-thickness arthroscopic rotator cuff repair (ARCR) surgery. Retear was defined as Sugaya Type IV or V retear/recurrence (full-thickness discontinuity seen on both coronal and oblique sagittal MRI images).
次要结局
- Number of Retears at 3 Months, 12 Months, and 24 Months(3 months, 12 months, and 24 months)
- Oxford Shoulder Score (OSS)(Baseline, 3 months, 6 months, 12 months and 24 months)
- Western Ontario Rotator Cuff (WORC) / Chinese Version WORC (C-WORC) Index(Baseline, 3 months, 6 months, 12 months and 24 months)
- Constant-Murley Score(Baseline, 3 months, 6 months, 12 months and 24 months)
- Subjective Shoulder Value (SSV)(Baseline, 3 months, 6 months, 12 months and 24 months)
- EuroQol 5 Dimension 5 Level (EQ-5D-5L) Index Score(Baseline, 3 months, 6 months, 12 months and 24 months)
- EuroQol 5 Dimension 5 Level (EQ-5D-5L) Visual Analog Scale (VAS) Score(Baseline, 3 months, 6 months, 12 months and 24 months)
- Patient Satisfaction Questionnaire: Medical Care(Baseline, 3 months, 6 months, 12 months and 24 months)
- Patient Satisfaction Questionnaire: How Well Did the Surgery Relieve the Pain(3 months, 6 months, 12 months and 24 months)
- Size of Retear: Anteroposterior (AP) Length(Day 0, 3 months and 6 months)
- Patient Satisfaction Questionnaire: How Well Did the Surgery Improve Your Ability to Perform Regular Activities(3 months, 6 months, 12 months and 24 months)
- Patient Satisfaction Questionnaire: How Well Did the Surgery Allow You to Perform Heavy Work or Sport Activities(3 months, 6 months, 12 months and 24 months)
- Patient Satisfaction Questionnaire: How Well Did the Surgery Meet Your Expectations(3 months, 6 months, 12 months and 24 months)
- Patient Satisfaction Questionnaire: Would You Have the Operation Again if Needed on Another Joint(3 months, 6 months, 12 months and 24 months)
- Pain - Visual Analog Scale (VAS) Score(2 weeks, 6 weeks, 3 months and 6 months)
- MRI Tendon Findings: Supraspinatus Sugaya Score(3 months, 6 months, 12 months and 24 months)
- MRI Tendon Findings: Infraspinatus Sugaya Score(3 months, 6 months, 12 months and 24 months)
- MRI Tendon Findings: Supraspinatus Goutallier Classification(3 months, 6 months, 12 months and 24 months)
- MRI Tendon Findings: Infraspinatus Goutallier Classification(3 months, 6 months, 12 months and 24 months)
- Total Tendon Thickness(3 months, 6 months, 12 months and 24 months)
- Total Tendon Length(3 months, 6 months, 12 months and 24 months)
- Size of Retear: Area (Anteroposterior [AP] / Mediolateral [ML])(Day 0, 3 months and 6 months)
- Size of Retear: Mediolateral (ML) Length(Day 0, 3 months and 6 months)
- Shape of Retear: Operative Visit(Day 0)
- Shape of Retear: 3 Months, 6 Months, 12 Months, and 24 Months(3 months, 6 months, 12 months and 24 months)
- Return to Work Questionnaire(2 weeks, 6 weeks, 3 months and 6 months)
- Return to Work Questionnaire: Reason for Not Getting Back to Work(2 weeks, 6 weeks, 3 months, 6 months)
- Return to Work Questionnaire: Reason Couldn't Return to Activities(2 weeks, 6 weeks, 3 months, 6 months)
- Return to Work Questionnaire: Time Off(2 weeks, 6 weeks, 3 months, 6 months)
- Return to Work Questionnaire: Duration Away From Work (Days)(2 weeks, 6 weeks, 3 months, 6 months)
- Duration of Opioid Use(Following surgery, up to 14 days)
- Opioid Use for More Than 5 Days Post-Surgery(Following surgery, up to 14 days)
- Total Operative Time(Intraoperative)
- Sling Type(up to 3 months)
- Mobilization Time in Sling(up to 3 months)
研究者
研究点 (59)
Loading locations...
相似试验
招募中
不适用
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff TearsRotator Cuff TearsNCT05997381CONMED Corporation268
已完成
4 期
Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row TechniqueRotator Cuff TearNCT02256891HealthPartners Institute97
招募中
4 期
Bioinductive Patch for Full-Thickness Rotator Cuff TearsRotator Cuff TearsRotator Cuff Tear ArthropathyNCT05439850Henry Ford Health System78
Unknown
不适用
Outcome of Arthroscopic Repair of Chronic Rotator Cuff Tears Between 2005-2008Rotator Cuff TearNCT00828256Soroka University Medical Center80
撤回
2 期
Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff RepairRotator Cuff TearsNCT04345666Orthopedic Institute, Sioux Falls, SD